In the quest for a longer, healthier life, understanding the intricacies of our body’s functions is key. One such crucial component is apolipoprotein B (apoB).

ApoB is like a delivery truck that carries cholesterol around in your body. Just like trucks transport goods to different places, apoB helps move cholesterol to various parts of your body where it’s needed. However, if there’s too much apoB, it’s like having too many trucks on the road, which can lead to traffic jams. In this case, they become blockages in your blood vessels. This is why keeping an eye on the amount of apoB in your blood is vital for keeping your heart and blood vessels healthy.

Here’s the technical details of what’s happening. ApoB exists in two primary forms: apoB-48 and apoB-100, each serving distinct functions in transporting fats within our body. Of particular interest is apoB-100, found in LDL (low-density lipoprotein), known as “bad” cholesterol. This protein facilitates the delivery of cholesterol to cells, but when in excess, it can lead to plaque buildup in arteries, heightening the risk of heart disease.

It’s important to note that the apoB test is not a standard part of routine blood work but is typically ordered for individuals with a known risk of cardiovascular disease or if a more detailed lipid analysis is needed. I consider that a failure of modern medicine.

Research has proven that measuring apoB can help predict one’s heart disease risk more accurately than a standard lipid panel, (which measures cholesterols and triglycerides.) If you have elevated levels of apoB-100, you’re at an increased risk of atherosclerosis, heart attacks, and strokes. When you know that elevated levels of this protein can directly cause problems, it seems ridiculous not to measure it.

Don't wait until you're experiencing risk factors; get a baseline to understand where your body is at now. Importantly, research shows that existing arterial plaque is one of the strongest predictors of future plaque progression, even stronger than apoB levels themselves. This reinforces why early screening and establishing baselines are crucial for cardiovascular health.

Because the relationship has been clearly defined, monitoring and managing apoB levels can be a critical strategy in preventing heart-related conditions.

UPDATE: 9/10/2025 Recent studies found something interesting: some very healthy, lean people can have high apoB levels without showing signs of increased heart problems. This seems to happen when people also have high "good" cholesterol and low triglycerides. For the majority of us, high apoB still signals increased risk of heart attacks and strokes.

In recent years, several new medicines have become available that make it easier to lower harmful cholesterol particles and reduce heart disease risk. Some medications, like PCSK9 inhibitors and inclisiran, are injections that help your liver clear more of the dangerous cholesterol-carrying particles from your blood. This leads to a big drop in your apoB levels.

There are also newer treatments in testing, such as special RNA-based medicines like solbinsiran, which work by turning down the body's production of certain proteins involved in cholesterol buildup. These options are especially helpful for people who cannot lower their cholesterol enough with diet, exercise, or regular pills like statins. They give doctors more ways than ever to protect heart health.

The other ways to keep your apoB-100 levels in check are the same things you hear from health and fitness professionals all the time. You’ve got to make consistent, mindful choices in daily life. Those choices include:

Embrace Heart-Healthy Nutrition: Choose a diet rich in fruits, vegetables, whole grains, and lean proteins. Limiting your intake of saturated fats and sugars can directly impact your apoB levels, steering you away from cardiovascular risks.

Stay Active: Regular exercise not only boosts your mood and energy but also helps regulate lipid levels, including apoB. Whether it’s a brisk walk, a swim, a workout in the gym or a dance class, find an activity that keeps you moving and engaged.

Maintain a Healthy Weight: Excess weight can influence various health markers, including apoB. Achieving and maintaining a healthy weight through balanced nutrition can significantly lower your risk.

Bid Farewell to Smoking: Smoking has a plethora of adverse effects on health, including elevating cardiovascular risk. Quitting smoking can improve your heart health and apoB levels.

Reduce or Eliminate Alcohol: In January of 2022, the World Heart Federation released a report stating that NO amount of alcohol is good for the heart. They didn’t say you should avoid beer, mixed drinks or go easy on the red wine. They said, “Based on recent evidence, it has been concluded that there is ‘no safe level of alcohol consumption.’”

Regular Health Check-ups: Staying informed about your health numbers, including apoB levels, allows you to take proactive steps towards maintaining heart health.

Understanding and managing your apoB levels can be a significant step towards enhancing your cardiovascular health and longevity. By incorporating healthy lifestyle choices and staying informed about your health metrics, you can pave the way for a heart-healthy, fulfilling life. Embrace these changes with optimism and dedication, and watch as they unfold into a healthier, vibrant you.

---

Reference Links:

Longitudinal Data From the KETO-CTA Study: Plaque Predicts Plaque, ApoB Does Not

Adrian Soto-Mota, Nicholas G Norwitz, Venkat S Manubolu, April Kinninger, Thomas R Wood, James Earls, David Feldman, Matthew Budoff
JACC: Advances, Published 2025 Apr 7.

Click Here for the Study: https://www.jacc.org/doi/10.1016/j.jacadv.2025.101686

 

ApoB, LDL-C, and non-HDL-C as markers of cardiovascular risk

Daniel Sehayek, Justine Cole, Elias Björnson, John T. Wilkins, Martin B. Mortensen, Line Dufresne, Karol M. Pencina, Michael J. Pencina, George Thanassoulis, Allan D. Sniderman Journal of Clinical Lipidology, Published 2025 Jun 6.

Click Here for the Study: https://www.sciencedirect.com/science/article/abs/pii/S1933287425003150

 

Long-term risk of a major cardiovascular event by apoB, apoA-1, and the apoB/apoA-1 ratio—Experience from the Swedish AMORIS cohort: A cohort study

Göran Walldius, Ulf de Faire, Lars Alfredsson, Karin Leander, Peter Westerholm, Håkan Malmström, Torbjörn Ivert, Niklas Hammar
PLOS Medicine, Published 2021 Dec 1.

Click Here for the Study: https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1003853

 

The apoB/apoA‐I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid‐lowering therapy – a review of the evidence

Göran Walldius, Ingmar Jungner
Journal of Internal Medicine, Published 2006 May.

Click Here for the Study: https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2796.2006.01643.x

 

Standardization of Apolipoprotein B, LDL‐Cholesterol, and Non‐HDL‐Cholesterol

John H. Contois, Michel R. Langlois, Christa Cobbaert, Allan D. Sniderman
Journal of the American Heart Association, Published 2023 Jul 25.

Click Here for the Study: https://www.ahajournals.org/doi/10.1161/JAHA.123.030405

 

Apolipoprotein B but not LDL Cholesterol Is Associated With Coronary Artery Calcification in Type 2 Diabetic Whites

Seth S. Martin, Atif N. Qasim, Nehal N. Mehta, Megan Wolfe, Karen Terembula, Stanley Schwartz, Nayyar Iqbal, Mark Schutta, Roshanak Bagheri, Muredach P. Reilly
Diabetes, Published 2009 Aug.

Click Here for the Study: https://pmc.ncbi.nlm.nih.gov/articles/PMC2712798/

 

Prediction of future cardiovascular disease with an equation to estimate apolipoprotein B in patients with high cardiovascular risk: an analysis from the TNT and IDEAL study

You-Cheol Hwang, Hong-Yup Ahn, Ki Hoon Han, Sung-Woo Park, Cheol-Young Park
Lipids in Health and Disease, Published 2017 Aug 22.

Click Here for the Study: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568138/

 

Physiological Bases for the Superiority of Apolipoprotein B Over Low‐Density Lipoprotein Cholesterol and Non–High‐Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk

Tamara Glavinovic, George Thanassoulis, Jacqueline de Graaf, Patrick Couture, Robert A. Hegele, Allan D. Sniderman
Journal of the American Heart Association, Published 2022 Oct 18.

Click Here for the Study: https://www.ahajournals.org/doi/10.1161/JAHA.122.025858

 

Apolipoprotein B: Bridging the Gap Between Evidence and Clinical Practice

Daniela De Oliveira-Gomes, Parag H. Joshi, Eric D. Peterson, Anand Rohatgi, Amit Khera, Ann Marie Navar
Circulation, Published 2024 Jul 2.

Click Here for the Study: https://pmc.ncbi.nlm.nih.gov/articles/PMC11219008/

 

ApoB-containing lipoproteins: count, type, size, and risk of coronary artery disease

Jakub Morze, Giorgio E.M. Melloni, Clemens Wittenbecher, Mika Ala-Korpela, Andrzej Rynkiewicz, Marta Guasch-Ferré, Christian T. Ruff, Frank B. Hu, Marc S. Sabatine, Nicholas A. Marston
European Heart Journal, Published 2025 Jul 14.

Click Here for the Study: https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehaf207/8118996

 

Long-term efficacy and safety of inclisiran in patients with high cardiovascular risk and elevated LDL cholesterol (ORION-3): results from the 4-year open-label extension of the ORION-1 trial

Kausik K. Ray, Roel P.T. Troquay, Frank L.J. Visseren, Lawrence A. Leiter, R. Scott Wright, Sheikh Vikarunnessa, Zsolt Talloczy, Xiao Zang, Pierre Maheux, Anastasia Lesogor, Ulf Landmesser
The Lancet Diabetes & Endocrinology, Published 2023 Feb.

Click Here for the Study: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(22)00353-9/fulltext

 

PCSK9 Inhibitors: The Evolving Future

Bijay Mukesh Jeswani, Shubhangi Sharma, Sawai Singh Rathore, Abubakar Nazir, Rohit Bhatheja, Kapil Kapoor
Health Science Reports, Published 2024 Oct 30.

Click Here for the Study: https://pmc.ncbi.nlm.nih.gov/articles/PMC11522611/

 

Call for a FREE Consultation (305) 296-3434
CAUTION: Check with your doctor before
beginning any diet or exercise program.

3/28/2024
Updated 9/10/2025